Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE [epsilon]4 allele

MLA

Rodriguez, Eloy, et al. “Cholesteryl Ester Transfer Protein (CETP) Polymorphism Modifies the Alzheimer’s Disease Risk Associated with APOE [Epsilon]4 Allele.” Journal of Neurology, vol. 253, no. 2, Feb. 2006, p. 181. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.152514553&authtype=sso&custid=ns315887.

APA

Rodriguez, E., Mateo, I., Infante, J., Llorca, J., Berciano, J., & Combarros, O. (2006). Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer’s disease risk associated with APOE [epsilon]4 allele. Journal of Neurology, 253(2), 181.

Chicago

Rodriguez, Eloy, Ignacio Mateo, Jon Infante, Javier Llorca, Jose Berciano, and Onofre Combarros. 2006. “Cholesteryl Ester Transfer Protein (CETP) Polymorphism Modifies the Alzheimer’s Disease Risk Associated with APOE [Epsilon]4 Allele.” Journal of Neurology 253 (2): 181. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.152514553&authtype=sso&custid=ns315887.